Program Directory
OCD and Anxiety
Autism and Anxiety and Mood Disorders
Eating Disorders
Depression and other Mood Disorders
Addiction
Trauma Recovery (PTSD)
Emotional Dysregulation
Why Choose Rogers
In this time of crisis, Rogers Connect Care is here for you. Learn more about our evidence-based treatment in a secure virtual environment. >
If you or someone you know is struggling with addiction to alcohol, opioids, or other substances, there is hope for recovery. We can help you gain the tools and insight to achieve and sustain sobriety. Learn more.
From August of 2014 until February of 2020, 487 adults admitted to our residential care completed measures at both admission and discharge. 41% were female and the mean age was 37 years (SD=13).
Many of our patients participate in our long term follow-up studies. Patients are contacted one year post discharge by telephone and email. Twelve months post discharge, the QIDS scores maintains at the mild level with patients reporting (m=7.06, SD=6.54) and a fair quality of life (m=64.13, SD= 13.26). The slight regressions are not statistically significant at follow-up.
The Quick Inventory of Depressive Symptomatology (QIDS) measures the overall severity of depression symptoms.
At time of admission to our residential care individuals report moderate depression, as measured by the QIDS (m= 12, SD=5.37); at time of discharge individuals report mild to no symptoms of depression (m= 6, SD=3.95). Utilizing paired sample t-tests, we find that these differences are statistically significant at the p< .001.
Scores range from 0-27. Higher scores indicate greater severity of depression symptoms.
Severity Range:
The Quality of Life Enjoyment and Satisfaction Questionnaire measures the overall enjoyment and satisfaction individuals experience across a number of life domains such as family relationships, work, hobbies, etc. Our goal is to improve the quality of life for those we treat.
Additionally, patients have statistical improvements in quality of life, measured by the Q-LES-Q-SF. Patients admitted with a poor to fair quality of life (m=48.4, SD=19.3), and discharged with a fair to good quality of life (m=74.9, SD=15.7) this is significant at the p<.001.
Though there is not an industry standard for interpreting score results, Rogers uses the following categories to evaluate our patients’ assessment of their quality of life:
References:
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., ... & Thase, M. E. (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological psychiatry, 54(5), 573-583.
Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology bulletin.
From April of 2017 until March of 2020, 415 adults admitted to our partial hospitalization care completed measures at both admission and discharge. 48.43% were female and the mean age was 35 years (SD=12.16).
At time of admission to our residential care individuals report moderate depression, as measured by the QIDS (m= 12.55, SD=5.35); at time of discharge individuals report mild to no symptoms of depression (m= 7.13, SD=4.79). Utilizing paired sample t-tests, we find that these differences are statistically significant at the p< .001.
Additionally, patients have statistical improvements in quality of life, measured by the Q-LES-Q-SF. Patients admitted with a poor to fair quality of life (m=50.01, SD=17.81), and discharged with a fair to good quality of life (m=64.90, SD=17.92) this is significant at the p<.001.
From February of 2018 until February of 2020, 1490 adults admitted to our addiction inpatient care completed measures at both admission and discharge. 39% were female and the mean age was 38.3 years (SD=12.4).
The Quick Inventory of Depressive Symptomatology (QIDS) measures the overall severity of depression symptoms. Higher scores indicate greater severity. Scores range from 0 to 27, higher scores indicate greater severity.
At time of admission, individuals report moderate depression, as measured by the QIDS (m= 13.2, SD=5.81); at time of discharge individuals report mild levels of depression (m=6.96, SD=4.97). Utilizing paired sample t-tests, we find that these differences are statistically significant at the p< .001.
From January 2017 until February of 2020, 214 adolescents admitted to our residential care completed measures at both admission and discharge. 56% male, 44% female, and the mean age was 16 years (SD=1.09). The average length of stay was 24 days.
At time of admission to our residential care individuals report moderate depression, as measured by the QIDS (m=12.4, SD =6); at time of discharge individuals report mild to no symptoms of depression (m=7.34, SD=4.53). Utilizing paired sample t-tests, we find that those differences are statistically significant at the p< .001.
The Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire is a 15-item self-report measure designed to measure the degree of enjoyment and satisfaction experienced by child and adolescent patients in various areas of daily functioning.
At time of admission to our residential care individuals report moderate depression, as measured by the PQLESQ (m=52.8, SD =17.3); at time of discharge individuals report mild to no symptoms of depression (m=66.4, SD=14.9). Utilizing paired sample t-tests, we find that those differences are statistically significant at the p< .001.
Read More
If you or someone you know is struggling with addiction to alcohol, opioids, or other substances, there is hope for recovery. We can help you gain the tools and insight to achieve and sustain sobriety.
Care Info
A specialist will, at no charge, recommend the appropriate level of care over the phone.
Free Screening
Take a short quiz to find out.
Take the quiz
Rogers Behavioral Health has more than 20 years of commitment and investment in outcomes studies, with nearly 10,000 of our patients participating. Patients who agree to participate are asked at admission and discharge to complete a series of questionnaires; follow-up calls on progress are made periodically after discharge.
Study findings are used by our treatment teams to examine the effectiveness of our clinical program and to make improvements. The findings are also presented at national and international conferences and published in peer-reviewed medical literature.
Overall, our outcome data consistently have shown that our residential and partial hospitalization treatment centers offer effective treatment, and newer studies under way are demonstrating similar consistency in outcomes for our partial hospital level of outpatient care. In selected programs where we have reached out one year after they leave the program, past patients report that they’ve been able to maintain the gains they made during treatment. With the implementation of our Cerner electronic health record, we are gaining additional understanding of our clinical effectiveness across service lines, levels of care and throughout our system, including our regional network of outpatient centers. With this knowledge, we are gaining insights that contribute to real-time adjustments in care and help us confirm the impact of evidence-based care upon outcomes.
English